CONCORDBIOPharmaceuticals
Concord Biotech Ltd — Balance Sheet
₹1018.40
-2.34%
Concord Biotech Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 10.46 Cr | 10.46 Cr | 10.46 Cr | 10.46 Cr | — |
| Share Issued | 10.46 Cr | 10.46 Cr | 10.46 Cr | 10.46 Cr | — |
| Total Debt | 2.97 Cr | 9.74 Cr | 31.55 Cr | 62.49 Cr | — |
| Tangible Book Value | 1.81K Cr | 1.53K Cr | 1.29K Cr | 1.10K Cr | — |
| Invested Capital | 1.81K Cr | 1.53K Cr | 1.32K Cr | 1.16K Cr | — |
| Working Capital | 951.18 Cr | 754.08 Cr | 535.86 Cr | 477.50 Cr | — |
| Net Tangible Assets | 1.81K Cr | 1.53K Cr | 1.29K Cr | 1.10K Cr | — |
| Capital Lease Obligations | 2.59 Cr | 3.51 Cr | 0.31 Cr | 1.91 Cr | — |
| Common Stock Equity | 1.81K Cr | 1.53K Cr | 1.29K Cr | 1.10K Cr | — |
| Total Capitalization | 1.81K Cr | 1.53K Cr | 1.30K Cr | 1.13K Cr | — |
| Total Equity Gross Minority Interest | 1.81K Cr | 1.53K Cr | 1.29K Cr | 1.10K Cr | — |
| Stockholders Equity | 1.81K Cr | 1.53K Cr | 1.29K Cr | 1.10K Cr | — |
| Other Equity Interest | 1.80K Cr | 1.52K Cr | — | — | — |
| Capital Stock | 10.46 Cr | 10.46 Cr | 10.46 Cr | 9.51 Cr | — |
| Common Stock | 10.46 Cr | 10.46 Cr | 10.46 Cr | 9.51 Cr | — |
| Total Liabilities Net Minority Interest | 221.53 Cr | 174.06 Cr | 223.98 Cr | 209.57 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 37.47 Cr | 31.91 Cr | 32.13 Cr | 54.40 Cr | — |
| Non Current Deferred Taxes Liabilities | 34.02 Cr | 28.06 Cr | 23.44 Cr | 20.97 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.63 Cr | 1.89 Cr | 6.40 Cr | 31.56 Cr | — |
| Long Term Capital Lease Obligation | 0.63 Cr | 1.89 Cr | 0.16 Cr | 0.31 Cr | — |
| Long Term Debt | 0.00 | 0.00 | 6.24 Cr | 31.25 Cr | — |
| Long Term Provisions | 2.82 Cr | 1.96 Cr | — | — | — |
| Current Liabilities | 184.06 Cr | 142.16 Cr | 191.84 Cr | 155.17 Cr | — |
| Other Current Liabilities | 11.32 Cr | 6.27 Cr | — | — | — |
| Current Debt And Capital Lease Obligation | 2.34 Cr | 7.85 Cr | 25.15 Cr | 30.93 Cr | — |
| Current Capital Lease Obligation | 1.96 Cr | 1.62 Cr | 0.15 Cr | 1.60 Cr | — |
| Current Debt | 0.38 Cr | 6.23 Cr | 25.00 Cr | 29.34 Cr | — |
| Current Provisions | 5.54 Cr | 3.90 Cr | 27.48 Cr | 1.75 Cr | — |
| Payables | 123.17 Cr | 126.64 Cr | 136.25 Cr | 106.80 Cr | — |
| Total Tax Payable | 10.13 Cr | 5.49 Cr | 9.00 Cr | 0.00 | — |
| Accounts Payable | 113.04 Cr | 94.44 Cr | 93.80 Cr | 83.11 Cr | — |
| Total Assets | 2.03K Cr | 1.70K Cr | 1.51K Cr | 1.31K Cr | — |
| Total Non Current Assets | 899.01 Cr | 804.48 Cr | 786.28 Cr | 680.13 Cr | — |
| Other Non Current Assets | 12.60 Cr | 7.98 Cr | — | — | — |
| Investmentin Financial Assets | 38.55 Cr | 0.00 | 0.12 Cr | 0.26 Cr | — |
| Available For Sale Securities | 38.55 Cr | 4.97 Cr | — | — | — |
| Long Term Equity Investment | 0.74 Cr | 2.06 Cr | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 1.12 Cr | 0.32 Cr | 0.20 Cr | 3.58 Cr | — |
| Other Intangible Assets | 1.12 Cr | 0.32 Cr | 0.20 Cr | 3.58 Cr | — |
| Net PPE | 844.22 Cr | 786.48 Cr | 765.48 Cr | 643.55 Cr | — |
| Gross PPE | 844.22 Cr | 1.02K Cr | 952.79 Cr | 781.40 Cr | — |
| Construction In Progress | 50.13 Cr | 211.48 Cr | 172.70 Cr | 74.16 Cr | — |
| Other Properties | 794.09 Cr | 51.99 Cr | 49.38 Cr | 43.22 Cr | — |
| Current Assets | 1.14K Cr | 896.23 Cr | 727.70 Cr | 632.67 Cr | — |
| Other Current Assets | 15.36 Cr | 28.49 Cr | 0.71 Cr | — | — |
| Inventory | 239.67 Cr | 207.95 Cr | 212.31 Cr | 195.12 Cr | — |
| Accounts Receivable | 521.65 Cr | 349.61 Cr | 273.76 Cr | 232.17 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 358.56 Cr | 285.53 Cr | 181.12 Cr | 161.78 Cr | — |
| Other Short Term Investments | 357.66 Cr | 270.39 Cr | 177.62 Cr | 161.11 Cr | — |
| Cash And Cash Equivalents | 0.90 Cr | 15.14 Cr | 3.50 Cr | 0.67 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Retained Earnings | — | 1.40K Cr | 1.17K Cr | 981.57 Cr | 877.72 Cr |
| Additional Paid In Capital | — | 81.97 Cr | 81.97 Cr | 82.92 Cr | 82.92 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 1.96 Cr | 2.30 Cr | 1.87 Cr | 2.10 Cr |
| Other Payable | — | 26.71 Cr | 33.46 Cr | 23.70 Cr | 24.34 Cr |
| Non Current Prepaid Assets | — | 11.13 Cr | 16.91 Cr | 28.44 Cr | 7.22 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 0.00 | 0.12 Cr | 0.26 Cr | 0.00 |
| Investmentsin Joint Venturesat Cost | — | 2.06 Cr | 0.00 | 0.00 | 0.37 Cr |
| Accumulated Depreciation | — | -238.46 Cr | -187.31 Cr | -137.85 Cr | -92.41 Cr |
| Machinery Furniture Equipment | — | 445.92 Cr | 429.45 Cr | 385.32 Cr | 336.15 Cr |
| Buildings And Improvements | — | 260.83 Cr | 246.55 Cr | 224.00 Cr | 200.23 Cr |
| Land And Improvements | — | 54.71 Cr | 54.71 Cr | 54.71 Cr | 54.70 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Hedging Assets Current | — | 0.12 Cr | 0.25 Cr | 0.50 Cr | 20000.00 |
| Restricted Cash | — | 5.68 Cr | 9.37 Cr | 1.01 Cr | 0.68 Cr |
| Prepaid Assets | — | 28.46 Cr | 21.20 Cr | 15.20 Cr | 38.39 Cr |
| Finished Goods | — | 16.60 Cr | 14.80 Cr | 22.19 Cr | 20.07 Cr |
| Work In Process | — | 123.48 Cr | 113.20 Cr | 90.18 Cr | 68.32 Cr |
| Raw Materials | — | 67.88 Cr | 84.31 Cr | 82.75 Cr | 65.22 Cr |
| Other Receivables | — | 18.88 Cr | 38.35 Cr | 26.89 Cr | 35.74 Cr |
| Allowance For Doubtful Accounts Receivable | — | -1.39 Cr | -0.87 Cr | -0.78 Cr | -1.13 Cr |
| Gross Accounts Receivable | — | 351.00 Cr | 274.63 Cr | 232.96 Cr | 178.64 Cr |
| Cash Financial | — | 15.14 Cr | 3.50 Cr | 0.67 Cr | 5.14 Cr |
| Net Debt | — | — | 27.74 Cr | 59.92 Cr | 81.20 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | — | 27.48 Cr | 1.75 Cr | 0.66 Cr |
| Taxes Receivable | — | — | — | 0.00 | — |
| Cash Equivalents | — | — | — | 0.00 | 50000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Concord Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.